Focus on Multiple Myeloma: Diagnosis, Therapy and Clinical Outcome
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Hematology".
Deadline for manuscript submissions: 20 June 2026 | Viewed by 14
Special Issue Editor
2. Faculty of Medicine, University of Basel, Klingelbergstrasse 61, 4056 Basel, Switzerland
Interests: multiple myeloma; bood and marrow transplantation; hematology; hematopoietic cell transplantation; Waldenström’s macroglobulinemia; AL amyloidosis; liver cancer; meta-analysis; immunotherapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Multiple myeloma (MM) is a complex hematological malignancy defined by abnormal plasma cell proliferation. Over the past decade, significant advances have been made in its diagnosis, diagnostic innovations, and treatment.
Prognosis and clinical outcome have improved substantially over the past two decades. Cytogenetic risk factors, depth of response, and minimal residual disease (MRD) status remain critical prognostic indicators.
While these advances have improved patient outcomes, ongoing research focuses on relapsed/refractory MM (RRMM): exploring novel therapies (CAR T-cell, BiTE), deciphering resistance mechanisms, testing non-immune options, and optimizing combination therapies to balance efficacy and safety. Moreover, ongoing research focuses on early detection, individualized therapy, and innovative therapeutic options towards a functional cure.
This Special Issue compiles cutting-edge research on MM progress, challenges, and future directions, welcoming submissions on advances in diagnosis, therapy, and its transition towards an improved clinical outcome and prognosis.
We are looking forward to your submissions.
Dr. Martina Kleber
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multiple myeloma
- novel therapies
- treatment approach
- prognosis
- clinical outcome
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
